Cargando…
Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens
The recent development in immune checkpoint inhibitors and chimeric antigen receptor (CAR) T‐cells in the treatment of cancer has not only demonstrated the potency of utilizing T‐cell reactivity for cancer therapy, but has also highlighted the need for developing new approaches to discover targets s...
Autores principales: | Ternette, Nicola, Olde Nordkamp, Marloes J. M., Müller, Julius, Anderson, Amanda P., Nicastri, Annalisa, Hill, Adrian V. S., Kessler, Benedikt M., Li, Demin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032843/ https://www.ncbi.nlm.nih.gov/pubmed/29786170 http://dx.doi.org/10.1002/pmic.201700465 |
Ejemplares similares
-
Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows
por: Partridge, Thomas, et al.
Publicado: (2018) -
Ionizing Radiation Drives Key Regulators of Antigen Presentation and a Global Expansion of the Immunopeptidome
por: Tailor, Arun, et al.
Publicado: (2022) -
Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from Theileria parva Infected Cells
por: Connelley, Timothy, et al.
Publicado: (2022) -
The Leukocyte Immunoglobulin-Like Receptor Family Member LILRB5 Binds to HLA-Class I Heavy Chains
por: Zhang, Zhiyong, et al.
Publicado: (2015) -
Novel insights into the HLA class I immunopeptidome and T-cell immunosurveillance
por: Melief, Cornelis J. M., et al.
Publicado: (2017)